Ojima Hidenori, Kanai Yae, Iwasaki Motoki, Hiraoka Nobuyoshi, Shimada Kazuaki, Sano Tsuyoshi, Sakamoto Yoshihiro, Esaki Minoru, Kosuge Tomoo, Sakamoto Michiie, Hirohashi Setsuo
Pathology Division, National Cancer Center Research Institute, Tokyo, Japan.
Cancer Sci. 2009 Jan;100(1):62-70. doi: 10.1111/j.1349-7006.2008.01009.x. Epub 2008 Nov 25.
The aim of this study is to evaluate the prognostic impact of an intraductal carcinoma component and bile duct resection margin status in patients with biliary tract carcinoma. An intraductal carcinoma component was defined as carcinoma within the bile duct outside the main tumor nodule consisting of a subepithelial invasive component. Surgically resected materials from 214 patients were evaluated by histological observations. Seventy-nine patients (36.9%) with an intraductal carcinoma component infrequently developed large tumors and infrequently showed deep invasion and venous, lymphatic and perineural involvement in the main tumor nodule. An intraductal carcinoma component was inversely correlated with advanced clinical stage, and was shown to be a significantly favorable prognostic factor by both univariate and multivariate analyses. Proximal (hepatic) side bile duct resection margin status was categorized into negative for tumor cells, positive with only an intraductal carcinoma component [R1 (is)], and positive with a subepithelial invasive component (R1). Forty-five patients (21.0%) with an R1 resection margin had a poorer prognosis than 148 patients (69.2%) with a negative resection margin, whereas 21 patients (9.8%) with an R1 (is) resection margin did not. In patients with an R1 resection margin, the risk of anastomotic recurrence was higher, and the period until anastomotic recurrence was shorter, than in patients with an R1 (is) resection margin. Surgeons should not be persistent in trying to achieve a negative surgical margin when the intraoperative frozen section diagnosis is R1 (is), and can choose a safe surgical procedure to avoid postoperative complications.
本研究旨在评估导管内癌成分及胆管切缘状态对胆道癌患者预后的影响。导管内癌成分定义为主要肿瘤结节以外胆管内包含上皮下浸润成分的癌。对214例患者手术切除的标本进行组织学观察。79例(36.9%)有导管内癌成分的患者较少发生大肿瘤,主要肿瘤结节较少出现深层浸润以及静脉、淋巴和神经周围侵犯。导管内癌成分与临床晚期呈负相关,单因素和多因素分析均显示其为显著有利的预后因素。近端(肝侧)胆管切缘状态分为肿瘤细胞阴性、仅导管内癌成分阳性[R1(原位)]和上皮下浸润成分阳性(R1)。切缘为R1的45例患者(21.0%)预后较切缘阴性的148例患者(69.2%)差,而切缘为R1(原位)的21例患者(9.8%)则不然。切缘为R1的患者吻合口复发风险更高,且吻合口复发时间短于切缘为R1(原位)的患者。当术中冰冻切片诊断为R1(原位)时,外科医生不应执意追求切缘阴性,可选择安全的手术方式以避免术后并发症。